• Event Type: Conference call for analysts and investors to discuss unaudited financial results for the quarter and half year ended September 30, 2026.
  • Date and Time: Tuesday, November 03, 2026 at 04:00 p.m. IST.
  • Purpose: Discussion of the company's unaudited financial results for Q2 and H1 FY26.
  • Timing Relative to Earnings: The call is scheduled after the earnings announcement for the specified period.
  • Management Participants: The announcement mentions management will be represented but does not specify individual names or designations beyond the Investor Relations contact.
  • Availability of Materials: The company states that the information about the conference call is being uploaded to the company website. No specific mention of presentations, earnings decks, transcripts, or recordings being made available.
  • UPSI Disclosure: The document is a regulatory filing under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Standard compliance language implies no unpublished price sensitive information (UPSI) will be shared, though not explicitly stated in the body text beyond the regulatory context.
  • Financial Data Disclosure: No financial figures, guidance references, or presentation summaries are included in this specific announcement.

Additional Notes Section

  • Attachments: The letter includes an enclosure notation (Encl.: As above) referring to the annexure containing dial-in details, which are provided in the body of the document.
  • Financial Data: Confirmed that no actual financial data or results were disclosed in this announcement. It is purely an intimation of the upcoming conference call.
  • Logistical Details: Dial-in numbers and a registration link are provided for operational access:
  • Primary Numbers: +91 22 6280 1403 / +91 22 7115 8304
  • International Numbers: USA: 1-866-746-2133, UK: 08081011573, Singapore: 8001012045, Hong Kong: 800964448, Canada: 01180014243444
  • Registration Link: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6597286&linkSecurityString=3a5d1ff608
  • Investor Relations Contact: Mr. Ronak Saraf, ir@advancedenzymes.com, +91 86578 64146